The S&P 500 hit a high. Tesla launched the new Model Y in the U.S. and Europe. AI stocks like Nvidia are testing key levels.
Merck & Co. and Eisai reported mixed results from a late-stage study of the cancer drugs Keytruda and Lenvima in patients with certain types of gastroesophageal cancer.